Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Hepatitis C treatment may cause frontal fibrosing alopecia.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

A new method effectively predicts estrogen-related health effects for early screening.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Iron deficiency can cause hair loss and often signals underlying health issues.

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

Migraines often worsen during perimenopause, but safe treatments are available.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.